Patient Groups Urge Congress To Support Biosimilars

Law360, New York (September 24, 2009, 6:14 PM EDT) -- A coalition of 27 patient advocacy groups is urging U.S. lawmakers working on massive health care reform to include bipartisan amendments creating a regulatory pathway for generic versions of biologic drugs.

In a letter to congressional leaders last week, Washington-based Colon Cancer Alliance and several other organizations said they supported amendments passed in U.S. House of Representatives and Senate committees to add a biosimilars provision to their health care proposals.

“In the face of the larger unresolved questions relating to the broader health care reform package,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.